[Answered] The pleasure that we have in response to beauty is said to be a. aesthetic. b. critical. c. ...

This topic contains a solution. Click here to go to the answer

Author Question: The pleasure that we have in response to beauty is said to be a. aesthetic. b. critical. c. ... (Read 37 times)

cmoore54

Hero Member
Posts: 568

on: Sep 28, 2018

The pleasure that we have in response to beauty is said to be

a. aesthetic.
b. critical.
c. humanistic.
d. impersonal.

Question 2

What is a spectacular?

What will be an ideal response?

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

livaneabi

Sr. Member
Posts: 328

Reply #1 on: Sep 28, 2018

Answer to Question 1

a

Answer to Question 2

A spectacular is a form of Broadway musical (such as Cats) that originated in the 1980s. It employs film-style special effects and huge operatic set pieces.

cmoore54

Member
Posts: 568

Reply 2 on: Sep 28, 2018

TYSM

nguyenhoanhat

Member
Posts: 332

Reply 3 on: Yesterday

Gracias!

« previous next »

Did you know?

An identified risk factor for osteoporosis is the intake of excessive amounts of vitamin A. Dietary intake of approximately double the recommended daily amount of vitamin A, by women, has been shown to reduce bone mineral density and increase the chances for hip fractures compared with women who consumed the recommended daily amount (or less) of vitamin A.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

Aspirin may benefit 11 different cancers, including those of the colon, pancreas, lungs, prostate, breasts, and leukemia.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.